July 22, 2025 - 04:32

Nvidia CEO Jensen Huang has expressed grave concerns about the United States' position in the global race for technological supremacy, particularly regarding artificial intelligence and the upcoming 6G network. In a recent statement, Huang emphasized that the U.S. cannot afford to repeat the mistakes made during the 5G rollout, which he believes was lost due to a combination of technological shortcomings, ineffective policies, and poor strategic decisions.
Huang's remarks highlight the urgency of maintaining a competitive edge in advanced technologies that are rapidly reshaping industries and economies worldwide. He stressed the importance of proactive measures to ensure that the U.S. remains at the forefront of innovation, particularly as countries around the globe invest heavily in AI and next-generation communication systems.
The call to action comes at a critical juncture, as advancements in AI and telecommunications are expected to have profound implications for the future. Huang's insights serve as a reminder of the need for strategic planning and collaboration to secure the nation's technological leadership.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...